Late-gadolinium enhancement predicts appropriate device therapies in nonischemic recipients of primary prevention implantable cardioverter-defibrillators
In patients with NICM and primary prevention ICDs, LGE ≥2% is predictive of appropriate device therapies but not all-cause mortality/LVAD/transplant. LGE may be a relatively specific predictor of sudden cardiac arrest risk and therefore could potentially be used during evaluation for prophylactic ICD implantation.
Authors
- Diane Rizkallah
- Christopher Nguyen (ORCID: https://orcid.org/0000-0003-1475-2329)
- Reza Nezafat (ORCID: https://orcid.org/0000-0002-1963-7138)
- Thomas Callahan (ORCID: https://orcid.org/0000-0001-5281-7598)
- Niraj Varma (ORCID: https://orcid.org/0000-0003-2296-2596)
- Alan Kiang
- Jakub Sroubek (ORCID: https://orcid.org/0000-0003-2490-5106)
- Pasquale Santangeli (ORCID: https://orcid.org/0000-0002-0023-9666)
- Justin Z. Lee (ORCID: https://orcid.org/0000-0003-2823-9243)
- Tom Kai Ming Wang (ORCID: https://orcid.org/0000-0001-5570-9402)
- Danah Al-Deiri
- Deborah Kwon
- Oussama Wazni
Institutions
- Beth Israel Deaconess Medical Center (US)
- Cleveland Clinic (US)
- Cleveland Foundation (US)
Publication Details
- Journal
- Heart Rhythm
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1016/j.hrthm.2025.01.003
- Citations
- 1
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Boston Scientific Corporation
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- Biosense Webster